search button
Open Access

Core‑shell type thermo‑nanoparticles loaded with temozolomide combined with photothermal therapy in melanoma cells

  • Authors:
    • Xiaoyang Hou
    • Yanyu Pang
    • Xinxin Li
    • Chunsheng Yang
    • Wenlou Liu
    • Guan Jiang
    • Yanqun Liu

  • View Affiliations

  • Published online on: September 20, 2019     https://doi.org/10.3892/or.2019.7329
  • Pages: 2512-2520

  • Copyright: © Hou et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

A novel core‑shell type thermo‑nanoparticle (CSTNP) co‑loaded with temozolomide (TMZ) and the fluorescein new indocyanine green dye IR820 (termed IT‑CSTNPs) was designed and combined with a near‑infrared (NIR) laser to realize its photothermal conversion. The IT‑CSTNPs were prepared using a two‑step synthesis method and comprised a thermosensitive shell and a biodegradable core. IR820 and TMZ were entrapped in the shell and the core, respectively. Dynamic light scattering results demonstrated that the average hydrodynamic size of the IT‑CSTNPs was 196.4±3.1 nm with a ζ potential of ‑24.9±1.3 mV. The encapsulation efficiencies of TMZ and IR820 were 6.1 and 16.6%, respectively. Temperature increase curves under NIR laser irradiation indicated that the IT‑CSTNPs exhibited the desired photothermal conversion efficiency. The in vitro drug release curves revealed a suitable release capability of IT‑CSTNP under physiological conditions, whereas NIR laser irradiation accelerated the drug release. Inverted fluorescence microscopy and flow cytometry results revealed that the uptake of IT‑CSTNPs by A375 melanoma cells occurred in a concentration‑dependent manner. Confocal laser scanning microscopy results indicated that IT‑CSTNPs entered tumour cells via endocytosis and were located in intercellular lysosomes. In summary, the present study explored the photothermal conversion capability, cellular uptake, and intracellular localization of IT‑CSTNPs.
View Figures
View References

Related Articles

Journal Cover

December-2019
Volume 42 Issue 6

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 3.8
  • Ranked Oncology
    (total number of cites)
  • CiteScore: 8.5
  • CiteScore Rank: Q1: #74/404 Oncology
  • Source Normalized Impact per Paper (SNIP): 0.719
  • SCImago Journal Rank (SJR): 0.864
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Hou X, Pang Y, Li X, Yang C, Liu W, Jiang G and Liu Y: Core‑shell type thermo‑nanoparticles loaded with temozolomide combined with photothermal therapy in melanoma cells. Oncol Rep 42: 2512-2520, 2019.
APA
Hou, X., Pang, Y., Li, X., Yang, C., Liu, W., Jiang, G., & Liu, Y. (2019). Core‑shell type thermo‑nanoparticles loaded with temozolomide combined with photothermal therapy in melanoma cells. Oncology Reports, 42, 2512-2520. https://doi.org/10.3892/or.2019.7329
MLA
Hou, X., Pang, Y., Li, X., Yang, C., Liu, W., Jiang, G., Liu, Y."Core‑shell type thermo‑nanoparticles loaded with temozolomide combined with photothermal therapy in melanoma cells". Oncology Reports 42.6 (2019): 2512-2520.
Chicago
Hou, X., Pang, Y., Li, X., Yang, C., Liu, W., Jiang, G., Liu, Y."Core‑shell type thermo‑nanoparticles loaded with temozolomide combined with photothermal therapy in melanoma cells". Oncology Reports 42, no. 6 (2019): 2512-2520. https://doi.org/10.3892/or.2019.7329